Literature DB >> 2394325

Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study.

R Löfberg1, O Broström, P Karlén, B Tribukait, A Ost.   

Abstract

In a 15-year surveillance program composed of 72 patients with total ulcerative colitis, 12 patients developed definite dysplasia. At endoscopy, low-grade dysplasia was detected in seven patients, high-grade in four, and a carcinoma (Dukes' stage A at operation) in one. One of the patients with high-grade dysplasia and macroscopical lesions at colonoscopy had a carcinoma (Dukes' A) detected at operation. A sequential development of dysplasia was found in seven patients. The cumulative risk of developing at least low-grade dysplasia was 14% after 25 years of disease duration. Using flow cytometric analyses, abnormal, aneuploid DNA content was detected in biopsies of 12 of 59 patients (20.3%); this correlated significantly with low-grade and high-grade dysplasia. Aneuploidy preceded dysplasia in two patients and was also detected in two dysplasia-free patients. The long-term use of colonoscopic surveillance in ulcerative colitis is a reliable way to select patients, in whom dysplasia is developing, for prophylactic surgery. Additionally, flow cytometric DNA analyses may help in the selection. The risk of missing a carcinoma until it becomes incurable appears to be low.

Entities:  

Mesh:

Year:  1990        PMID: 2394325     DOI: 10.1016/0016-5085(90)90622-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

Review 1.  Cancer surveillance in inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  1999-12

2.  Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

Authors:  C H Lim; M F Dixon; A Vail; D Forman; D A F Lynch; A T R Axon
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

3.  Screening for colorectal cancer in ulcerative colitis.

Authors: 
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

Review 4.  Inflammatory bowel disease: the problems of dysplasia and surveillance.

Authors:  P J Mitchell; E Salmo; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2007-11-30       Impact factor: 3.781

5.  Letters to the editor.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

6.  Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease.

Authors:  Alicia Algaba; Iván Guerra; Angel Castaño; Gema de la Poza; Víctor M Castellano; Montserrat López; Fernando Bermejo
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 7.  How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis?

Authors:  R H Riddell
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

Review 8.  How do we assess the value of surveillance techniques in ulcerative colitis?

Authors:  C N Bernstein
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

9.  DNA analysis with flow cytometry and image cytometry in colorectal polyps.

Authors:  F Torresan; L Zanella; A Mattarozzi; A Quiroga; P Bacchini; F Bertoni; L Gandolfi
Journal:  Surg Endosc       Date:  1994-12       Impact factor: 4.584

10.  Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease.

Authors:  M W M D Lutgens; B Oldenburg; P D Siersema; A A van Bodegraven; G Dijkstra; D W Hommes; D J de Jong; P C F Stokkers; C J van der Woude; F P Vleggaar
Journal:  Br J Cancer       Date:  2009-10-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.